BNGO · Bionano Genomics, Inc. · Earnings Call Transcripts & Audio
$1.56
-0.17 (-9.83%)
At close · Sep 30
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has prepared cash flows forecasts which indicate that based on the Company’s expected operating losses and negative cash flows, there is substantial doubt about the Company’s ability to continue as a going concern within twelve months after the date that the unaudited condensed consolidated financial statements for the six months ended June 30, 2026, are issued.”View the 10-Q filed Aug 10, 2026
Market Cap
$20.37M
Shares
11.78M
Volume · Sep 30
655.03K
Avg daily vol (3M)
910.17K
Bionano Genomics, Inc. Earnings Call Transcripts
Quarterly earnings calls for Bionano Genomics, Inc. (BNGO), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲73%
$6.67M
−$32.16M
'22 Q2
22-08-04
▲55.1%
$7.22M
−$31.81M
'22 Q3
22-11-03
▲30.4%
$8.21M
−$38.68M
'22 Q4
23-01-05
▲30.2%
$7.42M
−$37.12M
'23 Q1
23-04-24
▲29.9%
$8.66M
−$38.91M
'23 Q2
23-08-09
▲29%
$9.32M
−$112.57M
'23 Q3
23-10-11
▲30.5%
$10.72M
−$43.89M
'23 Q4
24-01-08
▲18.3%
$8.77M
−$31.42M
'24 Q1
24-05-08
▼10.3%
$7.77M
−$16.22M
'24 Q2
24-08-07
▼34.8%
$6.07M
−$44.25M
'24 Q3
24-11-13
▼26.4%
$6.46M
−$3.10M
'25 Q1
25-05-14
▼13.4%
$6.73M
−$6.86M
'25 Q2
25-08-14
▲21.3%
$7.37M
−$8.50M
'25 Q3
25-11-13
▼2.6%
$7.95M
−$7.93M
'25 Q4
26-03-23
▲3.6%
$6.69M
−$8.30M
'26 Q1
26-05-13
LATEST
▲21.4%
$8.17M
−$7.42M
'26 Q2
26-08-10
Earnings call
FY26 · Q2
2026-08-10
Bionano Genomics, Inc. (BNGO) Q2 2026 Earnings Call Transcript
Confident tone
Clinical adoption and consumables growth
OGM utilization and installed base
Software and VIA expansion
Revenue
$8.17M
▲ 21.4% YoY Diluted EPS
$-0.64
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Bionano Genomics, Inc. (BNGO) Q1 2026 Earnings Call Transcript
Positive tone
OGM Installed Base & Utilization
Reimbursement & CPT Codes
Publications & Clinical Evidence
Revenue
$6.69M
▲ 3.6% YoY Diluted EPS
$-0.76
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-23
Bionano Genomics, Inc. (BNGO) Q4 2025 Earnings Call Transcript
Positive tone
OGM scaling and key customer adoption
Gross margin and cost transformation
Reimbursement and guideline inclusion
Revenue
$7.95M*
▼ 2.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-13
Bionano Genomics, Inc. (BNGO) Q3 2025 Earnings Call Transcript
Positive tone
Routine user utilization strategy
Publications and clinical evidence
Revenue and product mix
Revenue
$7.37M
▲ 21.3% YoY Diluted EPS
$-1.59
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
Bionano Genomics, Inc. (BNGO) Q2 2025 Earnings Call Transcript
Positive tone
VIA software and digital pathology expansion
Strategic shift to routine user focus
Flow cell consumables growth
Revenue
$6.73M
▼ 13.4% YoY Diluted EPS
$-1.99
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Bionano Genomics, Inc. (BNGO) Q1 2025 Earnings Call Transcript
Balanced tone
Strategic shift to routine/high-utilization users
Cost reduction and profitability
Publications and clinical evidence
Revenue
$6.46M
▼ 26.4% YoY Diluted EPS
$-1.15
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q3
2024-11-13
Bionano Genomics, Inc. (BNGO) Q3 2024 Earnings Call Transcript
Cautious tone
Consumables utilization and flow cell growth
Stratys system commercialization
Revenue decline and guidance reduction
Revenue
$6.07M
▼ 34.8% YoY Diluted EPS
$-30.92
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
Bionano Genomics, Inc. (BNGO) Q2 2024 Earnings Call Transcript
Cautious tone
Stratys system adoption
Software and partnerships (VIA, Revvity)
Reimbursement and CPT code milestone
Revenue
$7.77M
▼ 10.3% YoY Diluted EPS
$-14.41
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Bionano Genomics, Inc. (BNGO) Q1 2024 Earnings Call Transcript
Positive tone
Biopharma and OGM adoption
Ionic purification system
Cost reduction and cash runway
Revenue
$8.77M
▲ 18.3% YoY Diluted EPS
$-35.75
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-08
Bionano Genomics, Inc. (BNGO) Q4 2023 Earnings Call Transcript
Balanced tone
Revenue growth and installed base expansion
Stratys system adoption
Cost reduction and restructuring
Revenue
$10.72M*
▲ 30.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-11
Bionano Genomics, Inc. (BNGO) Q3 2023 Earnings Call Transcript
Revenue
$9.32M
▲ 29% YoY Diluted EPS
$-193.20
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Bionano Genomics, Inc. (BNGO) Q2 2023 Earnings Call Transcript
Revenue
$8.66M
▲ 29.9% YoY Diluted EPS
$-74.40
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-24
Bionano Genomics, Inc. (BNGO) Q1 2023 Earnings Call Transcript
Revenue
$7.42M
▲ 30.2% YoY Diluted EPS
$-73.80
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-05
Bionano Genomics, Inc. (BNGO) Q4 2022 Earnings Call Transcript
Revenue
$8.21M*
▲ 30.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Bionano Genomics, Inc. (BNGO) Q3 2022 Earnings Call Transcript
Revenue
$7.22M
▲ 55.1% YoY Diluted EPS
$-66.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Bionano Genomics, Inc. (BNGO) Q2 2022 Earnings Call Transcript
Revenue
$6.67M
▲ 73% YoY Diluted EPS
$-67.80
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Bionano Genomics, Inc. (BNGO) Q1 2022 Earnings Call Transcript
Revenue
$5.70M
▲ 79.8% YoY Diluted EPS
$-66.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-01
Bionano Genomics, Inc. (BNGO) Q4 2021 Earnings Call
Revenue
$6.30M*
▲ 58% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Bionano Genomics, Inc. (BNGO) Q3 2021 Earnings Call
Revenue
$4.66M
▲ 112% YoY Diluted EPS
$-42.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Bionano Genomics, Inc. (BNGO) Q2 2021 Earnings Call
Revenue
$3.86M
▲ 226.2% YoY Diluted EPS
$-42.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Bionano Genomics, Inc. (BNGO) Q1 2021 Earnings Call
Revenue
$3.17M
▲ 178.9% YoY Diluted EPS
$-24.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-07
Bionano Genomics, Inc. (BNGO) Q4 2020 Earnings Call Transcript
Revenue
$3.99M*
▲ 43% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-12
Bionano Genomics, Inc. (BNGO) Q3 2020 Earnings Call Transcript
Revenue
$2.20M
▼ 33.7% YoY Diluted EPS
$-48.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-24
Bionano Genomics, Inc. (BNGO) Q2 2020 Earnings Call Transcript
Revenue
$1.18M
▼ 45.7% YoY Diluted EPS
$-54.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-14
Bionano Genomics, Inc. (BNGO) Q1 2020 Earnings Call Transcript
Revenue
$1.14M
▼ 38.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-05
Bionano Genomics, Inc. (BNGO) Q4 2019 Earnings Call
Revenue
$2.79M
▼ 30.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–26 of 26 earnings calls